Involvement of tumor cell integrin αvβ3 in hematogenous metastasis of human melanoma cells

Clinical and Experimental Metastasis

Volumn 19, Issue 5, 2002, Pages 427-436

  Felding Habermann, Brunhilde ^a,b,c,e,f,g   Fransvea, Emilia ^a,b,c,e,f,g   O'Toole, Timothy E ^a,b,c,e,f,g   Manzuk, Lisa ^b,c,d,e,f,g   Faha, Barbara ^b,c,d,e,f,g   Hensler, Mary ^b,c,d,e,f,g  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Clinica Medica II   (Italy)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Ixsys Inc   (United States)

^e Biosite Incorporated   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g Nereus Pharmaceuticals Inc   (United States)

Author keywords

IIb 3; v 3; Integrin; Melanoma; Metastasis; MMP 2

Indexed keywords

ALPHA5 INTEGRIN; FIBRONECTIN; GELATINASE A; MATRIX PROTEIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; VITRONECTIN; VITRONECTIN RECEPTOR;

ARTICLE; CANCER GROWTH; CAUSE OF DEATH; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MELANOMA CELL; METASTASIS; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; HUMANS; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MELANOMA; MELANOMA, EXPERIMENTAL; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, VITRONECTIN; RNA, MESSENGER; RNA, NEOPLASM; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED; VITRONECTIN;

EID: 0036344265     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016377114119     Document Type: Article

References (42)

1. Integrins as signaling molecules and targets for tumor therapy
2. Dynamics of intercellular communication during melanoma development
3. Classical chemotherapy for metastatic melanoma
4. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression
5. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions
6. Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression
7. Involvement of integrin alpha V gene expression in human melanoma tumorigenicity
8. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen
9. Molecular role(s) for integrins in human melanoma invasion
10. Distinct biological consequences of integrin alpha v beta 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments
11. Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow
12. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor
13. Monitoring mRNA expression by polymerase chain reaction: The 'primer-dropping' method
14. 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function
15. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation
16. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis
17. Mechanisms for pro matrix metalloproteinase activation
18. Cell adhesion receptor expression during melanoma progression and metastasis
19. A mechanism for divalent cation regulation of beta 3-integrins
20. Multiple use of a signal transduction pathway in tumor cell invasion
21. Adhesion molecules and tumor metastasis: An update
22. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
23. Matrix metalloproteinases in tumour invasion and metastasis
24. Membrane-type matrix metalloproteinases
25. Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: Correlation with melanoma progression
26. Cellular activation of MMP-2 (Gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway
27. Thrombin-thrombomodulin activation of protein C facilitates the activation of progelatinase A
28. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
29. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
30. Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo
31. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin
32. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells
33. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo
34. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase
35. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells
36. The role of carboxy-terminal glycosaminoglycan-binding domain of vitronectin in cytoskeletal organization and migration of endothelial cells
37. The urokinase receptor is a major vitronectin-binding protein on endothelial cells
38. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix
39. Constitutive and regulated expression of vitronectin
40. Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix
41. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion
42. Smooth muscle cell matrix metalloproteinase production is stimulated via alpha(v)beta(3) integrin